Parallax Volatility Advisers, L.P. Aldeyra Therapeutics, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$6.11 - $8.16 $81,263 - $108,528	13,300 Added 13300.0%	13,400 $89,000
Q2 2023 Aug 14, 2023	SELL	$7.11 - $11.89 $341,991 - $571,909	-48,100 Reduced 99.79%	100 $0
Q1 2023 May 15, 2023	BUY	$5.77 - $9.93 $263,689 - $453,801	45,700 Added 1828.0%	48,200 $478,000
Q4 2022 Feb 14, 2023	BUY	$5.08 - $7.09 $12,700 - $17,725	2,500 New	2,500 $17,000
Q1 2022 May 16, 2022	SELL	$3.25 - $5.17 $32,500 - $51,700	-10,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.5 - $9.63 $35,000 - $96,300	10,000 New	10,000 $40,000

130

38M

764K

544K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $377M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.